6CM
CABA icon

683 Capital Management’s Cabaletta Bio CABA Stock Holding History

683 Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Sell
225,000
-163,562
-42% -$454K 0.06% 172
2025
Q4 		$851K Buy
+388,562
New +$963K 0.07% 157
2023
Q2 		– Sell
-17,000
Closed -$141K – 188
2023
Q1 		$141K Sell
17,000
-9,963
-37% -$93.2K 0.01% 212
2022
Q4 		$249K Buy
+26,963
New +$98.2K 0.02% 140
2022
Q1 		– Sell
-36,118
Closed -$137K – 361
2021
Q4 		$137K Buy
+36,118
New +$385K 0.01% 293

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return